11:05 AM EDT, 05/16/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Friday morning, declining 0.48% to 1,424.92 on the S&P Europe Select ADR Index, which is up 1.4% for the week.

From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company Cellectis ( CLLS ) , which rose 3.4% and 2.1% respectively. They were followed by 3D printer company Materialise (MTLS) and pharmaceutical company Ascendis Pharma (ASND), which were up 1.5% and 1.4% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and pharmaceutical company Novo Nordisk ( NVO ) , which fell 4% and 3.6% respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and accommodations booking company trivago (TRVG), which were down 2.5% and 2.3% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 10% and 3.5% respectively. They were followed by tobacco company British American Tobacco ( BTI ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which increased 2.6% and 2.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which dropped 14% and 3.1% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and mining company BHP Group ( BHP ) , which lost 2.8% and 1.2% respectively.